Rocket Pharmaceuticals's total assets for Q3 2024 were $393.69M, a decrease of -11.81% from the previous quarter. RCKT total liabilities were $63.92M for the fiscal quarter, a 3.47% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.